Form 4 for ABT Abbott Laboratories
Accepted 2023-05-02 00:00:00 ET · period of report 2023-04-28 · accession 0001415889-23-007138 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-02 | 2023-04-28 | ABT | Roman Michael F | Dir | A - Grant | $0.00 | +1,816 | 4,977 | +57% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2023-04-28 | A | A | 1,816 | $0.00 | 4,977 | D | — | — | (F1) These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). (F2) Includes 60 shares that were acquired before Mr. Roman became an Abbott director and were not previously reported. |